Impact of community pharmacist antibiotic prescribing for minor ailments: an interrupted time series analysis
Leung V, Langford B, Brown KA, Ghahramani D, Hoang J, Oberai A, Tadrous M, Daneman N, Saqib K, Schwartz K. BMJ Open. 2025; 15(11): e107109.
Publications
Group B Streptococcus disease during infancy and risk of subsequent neurodevelopmental impairments in young children: a population-based cohort study in Ontario, Canada
Fakhraei R, Fell DB, El-Chaar D, Thampi N, Sander B, Brown KA, Crowcroft N, Bolotin S, Barrett J, Darling EK, Fittipaldi N, Lamagni T, McGeer A, Murti M, Sadarangani M, Schwartz KL, Yasseen A, Tunis M, Petrcich W, Wilson K. Lancet Reg Health Am. 2025; 48: 101170.
Limited durability of protection conferred by XBB.1.5 vaccines against omicron-associated severe outcomes among community-dwelling adults, Ontario, Canada
Lee N, Nguyen L, Nasreen S, Austin PC, Brown KA, Buchan SA, Grewal R, Schwartz KL, Tadrous M, Wilson K, Wilson SE, Kwong JC; Canadian Immunization Research Network (CIRN) Investigators. Vaccine. 2025; May 26 [Epub ahead of print].
The burden of antimicrobial resistant bacteremia in Ontario: a population-wide analysis of attributable mortality from 110 pathogen-antibiotic combinations
Brown KA, Fridman DJ, Garber GE, Johnstone J, Langford BJ, Leung V, MacFadden D, Patel SN, Schwartz KL, Sander B, Daneman N. Clin Infect Dis. 2025; ciaf213 Epub 2025 May 13.
Patterns of outpatient antibiotic prescribing in older adults by social determinants of healthcare access: a population-based retrospective cohort study
Sapin ME, Maxwell CJ, Clarke AE, Cooper C, So M, Schwartz KL, Daneman N, Mishra S, MacFadden D. Clin Microbiol Infect. 2025; S1198-743X(25)00086-2.
Evaluating harms associated with prolonged antibiotic duration of therapy in community dwelling older adults: a cohort study using instrumental variable analysis
Langford BJ, Brown KA, Lau C, Calzavara A, Krueger C, Leung V, Daneman N, Schwartz KL. Clin Infect Dis. 2024; Dec 30 [Epub ahead of print].
Prevalence and predictors of concomitant bacterial infections in patients with respiratory viruses in Ontario: a cohort study
Wang Y, Swayze S, Brown KA, MacFadden DR, Lee SM, Schwartz KL, Daneman N, Langford BJ. Open Forum Infect Dis. 2024; 11(12):ofae701.
Long-term risk of infection among patients colonized with antimicrobial-resistant pathogens: a population-wide cohort study
Blagojevic C, Brown KA, Diong C, Fridman DJ, Johnstone J, Langford BJ, Lee SM, MacFadden DR, Schwartz KL, Daneman N. Open Forum Infect Dis. 2024 Dec 2; 11(12):ofae712.
COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: a Canadian immunization research network (CIRN) study
Piché-Renaud PP, Drover SSM, Austin PC, Morris SK, Buchan SA, Nasreen S, Schwartz KL, Tadrous M, Thampi N, Wilson SE, Wilson K, Guttmann A, Kwong JC. Vaccine. 2024; Nov 30 [Epub ahead of print].
Burden of infant group B Streptococcus disease and impact of maternal screening and antibiotic prophylaxis in Ontario, Canada: a population-based cohort study
Fakhraei R, Fell DB, El-Chaâr D, Thampi N, Sander B, Brown KA, Crowcroft N, Bolotin S, Barrett J, Darling EK, Fittipaldi N, Lamagni T, McGeer A, Murti M, Sadarangani M, Schwartz KL, Yasseen A, Tunis M, Petrcich W, Wilson K. Lancet Reg Health Am. 2024; 39:100914.